Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Mesenchymal stem cells (MSC) has a therapeutic potential for Alzheimer's disease (AD) targeting various mechanisms including neuroprotective, immunomodulatory, and antioxidant action. The purpose of this study is to clarify the effect and treatment mechanism of MSC treatment on AD model mice. Transplantation of MSC ameliorated amyloid beta pathology in AD model mice through modifying amyloid beta clearance by microglia and improving the unbalanced redox status of the AD model mouse brain, thereby improving cognitive function.
|